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To evaluate whether green tea consumption provides protection against stomach cancer, the relative risks (RRs) were calculated in
the Japan Collaborative Study for Evaluation of Cancer Risk, sponsored by the Ministry of Health and Welfare (JACC Study). The
study was based on 157 incident cases and 285 controls aged 40–79 years. Cox proportional hazards regression analysis was used to
estimate the RRs for stomach cancer. It was found that green tea consumption had no protective effect against stomach cancer. After
adjustment for age, smoking status, H. pylori infection, history of peptic ulcer, and family history of stomach cancer along with certain
dietary elements, the risks associated with drinking one or two, three or four, five to nine, and 10 or more cups of green tea per day,
relative to those of drinking less than one cup per day, were 1.3 (95% confidence interval (CI): 0.6–2.8), 1.0 (95% CI: 0.5–1.9), 0.8
(95% CI: 0.4–1.6), and 1.2 (95% CI: 0.6–2.5), respectively (P for trend¼0.899). We found no inverse association between green tea
consumption and the risk of stomach cancer.
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Stomach cancer is the second most common cancer worldwide
(Parkin et al, 1999). In Japan, this cancer is the leading cause of
cancer death among women and the second among men (Statistics
and Information Department, Minister’s secretariat, Ministry of
Health and Welfare Japan, 2000). It has recently been reported that
green tea consumption is inversely associated with the risk of
stomach cancer; in other words, it has a protective effect. Green tea
polyphenols have various anticarcinogenic effects, such as strong
antioxidant activity, and inhibition of nitrosation and cell
proliferation.
Although case–control studies (Kono et al, 1988; Yu and Hsieh,
1991; Yu et al, 1995; Ji et al, 1996; Inoue et al, 1998; Setiawan et al,
2001) have found a reduced risk of stomach cancer in association
with green tea consumption, prospective studies (Galanis et al,
1998; Nakachi et al, 2000; Nagao et al, 2001; Tsubono et al, 2001)
have not. A recent prospective study found that green tea had a
protective effect against stomach cancer. Urinary tea polyphenols
have been associated with protection from the risk of stomach
cancer, while controlling Helicobacter pylori infection. Past studies
did not consider the presence or absence of a history of infection
with H. pylori, a strong risk factor for stomach cancer (Asaka et al,
1997). Assuming that green tea consumption is related to H. pylori
infection, when a subject has a history of infection with H. pylori
and consumes a large quantity of green tea, the protective effect, if
any, would be masked. The present nested case–control study
aimed to examine the association between green tea consumption
and the risk of stomach cancer, while controlling H. pylori
infection and other potential confounders, using data from the
Japan Collaborative Cohort (JACC) Study, a Japan-wide popula-
tion-based prospective study. This is the first study to analyse the
effects of green tea consumption while controlling H. pylori
infection.
MATERIAL AND METHODS
JACC Study
This study was part of the Japan Collaborative Cohort Study for
Evaluation of Cancer Risk sponsored by the Ministry of Education,
Science, Sports and Culture of Japan (the JACC Study), a nation-
wide multicentre collaborative study to prospectively evaluate
various risk or protective factors for cancer mortality and
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Briefly, the cohort included 110792 men and women (46465 and
64327, respectively), aged 40–79 years at recruitment, who were
enrolled from 1988 to 1990. Enrollment was based on the
participants of a general health checkup periodically provided by
the 45 municipalities involved. The informed consent procedures
were approved by the Ethics Committee of Medical Care and
Research, University of Occupational and Environmental Health,
Kitakyushu, and the Ethical Board of the Nagoya University School
of Medicine, Japan.
At the time of recruitment, baseline characteristics were
gathered by a self-administered questionnaire, which covered
the medical history and included items such as drinking and
smoking, level of education, and family history of several medical
conditions including cancer. About one-third of the cohort
members (n¼39293) also donated a residual serum sample
(about 2ml) to be used for the general health checkup. This sample
was partitioned into 0.3–0.5ml aliquots and stored at  801C,
until laboratory analyses were performed. The H. pylori antibody
level was measured in the serum using HM-CAPTM (Enteric
Products, Westbury, NY, USA) with an antigen from Japanese
(J-HM-CAP). The cutoff value was determined at 2.3, which was
recommended in the manufacturer’s instructions.
Follow-up and identification of stomach cancer cases, and
selection of control subjects
The vital status of each participant was checked annually by
each regional research centre, with permission from the Ministry
of Public Management, Home Affairs, Post and Telecommunica-
tions to review their population register sheets. The incidence
of cancer was ascertained in 24 study areas (n¼65184) and coded
according to the tenth revision of the International Classification
of Disease and the second edition of the International
Classification of Diseases for Oncology. These data were collected
at the central office of the Research Committee.
We first restricted the subjects to those who lived in the
study areas where cancer incidence was ascertained. We then
excluded 857 participants with a self-reported history of cancer.
From the remaining 64327 subjects, diagnosis of stomach
cancer at 12 or more months after cohort recruitment was
documented in 804 subjects until the end of 1997. Serum had been
obtained from 218 cases of the initial 804 cases. However,
seven cases without sufficient serum for the laboratory analyses
and one case without an eligible control subject were excluded.
Thus, the study reported here included 210 cases in total.
There were no differences between those selected for the
case–control study nested within the cohort and those who were
not selected in terms of the variables included in the multivariate
model. The lag time between blood sampling and stomach cancer
diagnosis varied between 12 and 113 months (median, 50 months).
Each of these subjects was matched with two control subjects
with respect to sex, age at recruitment (as near as possible), and
study area, who had also provided an adequate baseline
blood sample, and who were alive and free of confirmed cancer
by the end of 1997. Owing to a lack of eligible subjects, a few sets
(n¼10) contained only one control, and thus there was a total of
410 controls.
Since questions on the daily consumption of green tea were not
included in the questionnaire in seven areas (four rural areas
and three urban/rural areas), we excluded these data (49 cases and
88 controls). Of the 161 cases and 322 controls remaining, eight
cases (5.0%) and 38 controls (11.8%) had green tea consumption
data missing from the questionnaire; so these too were excluded.
Owing to a lack of eligible subjects, 16 sets were further
excluded. The remaining 151 cases and 265 controls were included
in the present analysis.
Data processing
Cox proportional hazard regression analysis was used. The relative
risk (RR) and its 95% confidence interval (CI) were calculated
based on the regression coefficient and its standard error (Cox,
1972), for an indicator term corresponding to the level of an
independent variable. For multivariate analysis, several factors
were listed as potential confounders according to epidemiological
studies (Boeing, 1991; Hoshiyama and Sasaba, 1992; World Cancer
Research Fund, 1997; Hoshiyama et al, 2002; Yatsuya et al, 2002).
Trends of association were assessed by the regression model
assigning scores (0–4) to the levels of the independent variables.
Statistical significance (two-sided) was based on the ratio of the
regression coefficient and its standard error. Statistical analysis
(PHREG procedure) was performed using the Statistical Analysis
System (SAS Institute, 1983).
RESULTS
Table 1 compares the characteristics of the cases and the controls.
The consumption of green tea varied substantially. The proportion
with a history of H. pylori infection was higher for the cases than
for the controls. The proportion with a family history of stomach
cancer was also higher for the cases than for the controls. The
proportion of current smokers was also higher for the cases than
for the controls. The cases consumed rice, miso soup, green–
yellow vegetables, and fruit more frequently than the controls.
Table 2 shows the RR and its CI for stomach cancer according to
green tea consumption. The age/sex-adjusted RRs associated with
drinking one or two, three or four, five to nine, and 10 or more
cups of green tea per day, relative to those of drinking less than
one cup per day, were 1.2 (95% CI: 0.5–2.9), 0.9 (95% CI: 0.4–1.9),
0.7 (95% CI: 0.3–1.5), and 1.0 (95% CI: 0.4–2.4), respectively.
Multivariate RRs were similar to age/sex-adjusted and age/sex- and
H. pylori infection-adjusted RRs.
Table 1 Characteristics of cases and controls
Case Control
No 151 265
Age (years) 61.7 61.5
Green tea (cups per day)
o11 8 3 1
1 or 2 19 23
3 or 4 41 73
5–9 50 105
X10 23 33
H. pyroli infection (%) 88.7 77.7
History of peptic ulcer (%) 19.7 18.2
Family history of stomach cancer (%)
a 20.5 16.2
p9 years of schooling (%)
b 37.1 32.0
Smoking (%)
Current 32.2 28.7
Past 18.5 18.0
Daily dietary consumption (%)
Rice (X4 bowlsday
 1) 36.5 31.8
Miso soup (X1 cupday
 1) 83.7 77.9
Preference for salty foods (yes) 33.8 29.6
Green-yellow vegetables (X1day
 1) 46.7 42.3
White vegetables (X1day
 1) 38.6 40.5
Fruits (X3week
 1) 44.4 39.3
aWe defined a positive family history of stomach cancer as when the subject had a
least one first-degree relative (parents or siblings) with a history of stomach cancer.
bInformation on educational level was measured as the age of formal schooling
completed and was classified into two categories: p15 years old (corresponds to
p9 years of schooling) and X16 years old (corresponds to X10 years of schooling).
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positivity according to green tea consumption. H. pylori infection
did not differ with the consumption of green tea.
DISCUSSION
This nested case–control study is the first study to investigate any
association between green tea consumption and the risk of
stomach cancer while controlling H. pylori infection. Among the
possible limitations of the present study was incomplete data.
About 10% of subjects were excluded from the analysis because
they had not provided information concerning their daily
consumption of green tea. We could not fully evaluate the effects
of the exclusion of these data. Nevertheless, there was no difference
between the percentages of smokers in the whole data (53.1% of
men and 2.9% of women) and those in the included data (51.9%
and 3.7%, respectively), as examined by the Cochran–Mantel–
Haenszel w
2 test (P¼1.000 and 0.843, respectively). The missing
information therefore seemed to occur randomly.
The second possible problem with the present study was in the
questionnaire. The original words of the question on green tea
were: Do you drink Japanese tea (green tea)? There are various
kinds of Japanese tea, although for Japanese people green tea is the
one that most often comes to mind. About 89% of the total
production of Japanese tea in 1999 was ordinary green tea (The
Ministry of Agriculture, Forestry, and Fisheries, 1999). We believe
that a slight misclassification could have derived from the
idiosyncrasy of our questionnaire pertaining to Japanese tea
(green tea).
Green tea is widely consumed in Japan and other Asian
countries. If drinking green tea protects against stomach cancer,
it would be an inexpensive and convenient method of primary
prevention. Tsubono et al reported that there was no association
between green tea consumption and the risk of stomach cancer,
consistent with the finding of this prospective study. Little other
evidence is available from prospective studies (Galanis et al, 1998;
Tsubono et al, 2001). Past studies did not consider the influence of
H. pylori infection. Subjects with chronic gastritis caused by H.
pylori infection might have limited their consumption of green tea.
If so, the prevalence of infection would have been lower in the
subjects with higher intakes of green tea. If not, the prevalence of
infection would have been higher among the subjects with
higher intakes of green tea. This condition would have masked
an inverse association between the risk of stomach cancer and
green tea consumption. We examined the association of H. pylori
infection and green tea consumption, and found that H. pylori
infection did not differ with the consumption of green tea (see
Table 3).
Our findings are in general agreement with those of four
prospective studies which found no inverse association between
green tea consumption and the risk of stomach cancer (Galanis
et al, 1998; Nakachi et al, 2000; Nagao et al, 2001; Tsubono et al,
2001). The number of cases of stomach cancer was relatively large
in three studies. Recently, another prospective study was
conducted in Shanghai, China. Urinary EGC positivity showed a
statistically significant inverse association with stomach cancer
(OR¼0.52, 95% CI¼0.28–0.97) after adjustment for H. pylori
seropositivity, smoking, alcohol drinking, and the level of serum
carotenes (Sun et al, 2002). Cumulative excretion of EGC increased
with increasing green tea consumption in human subjects (Yang
et al, 1998). It might be important to evaluate biomarkers of tea
polyphenol exposure.
In summary, we found no inverse association between the
consumption of green tea and the risk of stomach cancer in Japan
in a nested case–control study.
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